<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.2?><?ConverterInfo.XSLTName jats2jats3.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Chem Sci</journal-id><journal-id journal-id-type="iso-abbrev">Chem Sci</journal-id><journal-id journal-id-type="publisher-id">SC</journal-id><journal-id journal-id-type="coden">CSHCBM</journal-id><journal-title-group><journal-title>Chemical Science</journal-title></journal-title-group><issn pub-type="ppub">2041-6520</issn><issn pub-type="epub">2041-6539</issn><publisher><publisher-name>The Royal Society of Chemistry</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">8159325</article-id><article-id pub-id-type="publisher-id">c9sc06192d</article-id><article-id pub-id-type="doi">10.1039/c9sc06192d</article-id><article-categories><subj-group subj-group-type="heading"><subject>Chemistry</subject></subj-group></article-categories><title-group><article-title>Mixing and matching genes of marine and terrestrial origin in the biosynthesis of the mupirocin antibiotics<xref ref-type="fn" rid="fn1">&#x02020;</xref></article-title><fn-group><fn id="fn1"><label>&#x02020;</label><p>Electronic supplementary information (ESI) available. See DOI: <uri>10.1039/c9sc06192d</uri></p></fn></fn-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-2032-7206</contrib-id><name><surname>Wang</surname><given-names>Luoyi</given-names></name><xref ref-type="aff" rid="affa"/></contrib><contrib contrib-type="author"><name><surname>Song</surname><given-names>Zhongshu</given-names></name><xref ref-type="aff" rid="affa"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0184-5630</contrib-id><name><surname>Race</surname><given-names>Paul R.</given-names></name><xref ref-type="aff" rid="affb"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-4602-0571</contrib-id><name><surname>Spencer</surname><given-names>James</given-names></name><xref ref-type="aff" rid="affc"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0777-1935</contrib-id><name><surname>Simpson</surname><given-names>Thomas J.</given-names></name><xref ref-type="aff" rid="affa"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-7868-5818</contrib-id><contrib-id contrib-id-type="resid" authenticated="false">P-4786-2015</contrib-id><name><surname>Crump</surname><given-names>Matthew P.</given-names></name><xref ref-type="aff" rid="affa"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-3919-3642</contrib-id><name><surname>Willis</surname><given-names>Christine L.</given-names></name><xref ref-type="aff" rid="affa"/></contrib><aff id="affa">
<institution>School of Chemistry, University of Bristol</institution>
<addr-line>Cantock's Close</addr-line>
<postal-code>BS8 1TS</postal-code>
<city>Bristol</city>
<country>UK</country>
<email>chris.willis@bristol.ac.uk</email>
<email>matt.crump@bristol.ac.uk</email>
</aff><aff id="affb">
<institution>School of Biochemistry, University of Bristol</institution>
<addr-line>University Walk</addr-line>
<postal-code>BS8 1TD</postal-code>
<city>Bristol</city>
<country>UK</country>
</aff><aff id="affc">
<institution>School of Cellular and Molecular Medicine, University of Bristol</institution>
<postal-code>BS8 1TD</postal-code>
<city>Bristol</city>
<country>UK</country>
</aff></contrib-group><pub-date publication-format="electronic" date-type="pub" iso-8601-date="2020-05-09"><day>9</day><month>5</month><year>2020</year></pub-date><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2020-05-28"><day>28</day><month>5</month><year>2020</year></pub-date><pub-date pub-type="pmc-release"><day>9</day><month>5</month><year>2020</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>11</volume><issue>20</issue><fpage>5221</fpage><lpage>5226</lpage><history><date date-type="received" iso-8601-date="2019-12-06"><day>6</day><month>12</month><year>2019</year></date><date date-type="accepted" iso-8601-date="2020-04-29"><day>29</day><month>4</month><year>2020</year></date></history><permissions><copyright-statement>This journal is &#x000a9; The Royal Society of Chemistry</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>The Royal Society of Chemistry</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense" start_date="2020-05-09">https://creativecommons.org/licenses/by/3.0/</ali:license_ref></license><?release-delay 0|0?></permissions><abstract><p>With growing understanding of the underlying pathways of polyketide biosynthesis, along with the continual expansion of the synthetic biology toolkit, it is becoming possible to rationally engineer and fine-tune the polyketide biosynthetic machinery for production of new compounds with improved properties such as stability and/or bioactivity. However, engineering the pathway to the thiomarinol antibiotics has proved challenging. Here we report that genes from a marine <italic>Pseudoalternomonas</italic> sp. producing thiomarinol can be expressed in functional form in the biosynthesis of the clinically important antibiotic mupirocin from the soil bacterium <italic>Pseudomonas fluorescens</italic>. It is revealed that both pathways employ the same unusual mechanism of tetrahydropyran (THP) ring formation and the enzymes are cross compatible. Furthermore, the efficiency of downstream processing of 10,11-epoxy <italic>versus</italic> 10,11-alkenic metabolites are comparable. Optimisation of the fermentation conditions in an engineered strain in which production of pseudomonic acid A (with the 10,11-epoxide) is replaced by substantial titres of the more stable pseudomonic acid C (with a 10,11-alkene) pave the way for its development as a more stable antibiotic with wider applications than mupirocin.</p></abstract><abstract abstract-type="toc"><p>Where the sea meets the land: the mupirocin biosynthetic gene cluster (BGC) from the terrestrial bacterium <italic>Pseudomonas fluorescens</italic> was repurposed <italic>via</italic> a plug-and-play approach with heterologous genes from the marine strain that produces thiomarinol.<graphic xlink:href="c9sc06192d-ga.jpg" id="ga" position="float" orientation="portrait"/></p></abstract><funding-group><award-group><funding-source><institution-wrap><institution>Engineering and Physical Sciences Research Council</institution><institution-id institution-id-type="doi">10.13039/501100000266</institution-id></institution-wrap></funding-source><award-id>EP/M027546/1</award-id></award-group><award-group><funding-source><institution-wrap><institution>Biotechnology and Biological Sciences Research Council</institution><institution-id institution-id-type="doi">10.13039/501100000268</institution-id></institution-wrap></funding-source><award-id>BB/L01386X/1</award-id><award-id>BB/R007853/1</award-id></award-group></funding-group><counts><page-count count="6"/></counts><custom-meta-group><custom-meta><meta-name>pubstatus</meta-name><meta-value>Paginated Article</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec><title>Introduction</title><p>Rapid acceleration in the emergence of antibiotic resistance in pathogenic bacteria is severely eroding our ability to treat bacterial infections.<sup><xref rid="cit1" ref-type="bibr">1</xref></sup> Central to an effective response to this problem is the development of novel antibiotics with activity against bacteria resistant to existing agents. A majority of antibiotics in clinical use are natural products or their derivatives, possessing chemotypes and properties often lacking in &#x0201c;drug-like&#x0201d; chemical libraries. Thus, rational engineering of natural product biosynthetic pathways for production of new compounds with improved stability and/or bioactivity is an attractive route to overcoming resistance.<sup><xref rid="cit2" ref-type="bibr">2</xref></sup> However, the success of such approaches requires detailed understanding of the biosynthetic process.<sup><xref rid="cit3" ref-type="bibr">3</xref></sup></p><p>The antibiotic mupirocin produced by <italic>Pseudomonas fluorescens</italic> NCIMB 10586 is among the most effective topical treatments for Gram-positive bacterial infections including methicillin resistant <italic>Staphylococcus aureus</italic> (MRSA).<sup><xref rid="cit4" ref-type="bibr">4</xref></sup> It was identified as one of the first examples of the now extensive family of antibiotics produced by the &#x0201c;<italic>trans</italic>-AT&#x0201d; class of modular polyketides synthases (PKSs).<sup><xref rid="cit5" ref-type="bibr">5</xref></sup> Mupirocin is a mixture of pseudomonic acids of which the major component (&#x0003e;90%, <xref ref-type="fig" rid="fig1">Fig. 1</xref>) is pseudomonic acid A (<bold>1</bold>, PA-A) assembled on a C<sub>17</sub>-polyketide derived moiety (monic acid) esterified by 9-hydroxynonanoic acid (9-HN).<sup><xref rid="cit6" ref-type="bibr">6</xref></sup> Further minor components of mupirocin include <italic>ca.</italic> 5% PA-B (<bold>2</bold>) containing an additional 8-hydroxyl group and a minor product, &#x0003c;1%, PA-C (<bold>3</bold>), with a 10,11-alkene rather than the 10,11-epoxide found in PA-A and PA-B. Studies on mupirocin biosynthesis including analyses of wild-type and mutant strains of <italic>P. fluorescens</italic> and chemical complementation studies have revealed that PA-B is formed first and contains the tetrahydropyran (THP) ring necessary for activity as shown in <xref ref-type="fig" rid="fig1">Fig. 1A</xref>.<sup><xref rid="cit7" ref-type="bibr">7</xref></sup> The 8-OH is subsequently lost through a series of transformations which begins with oxidation at C-6 to form mupirocin P (<bold>4</bold>), requiring the enzymes MupU (CoA ligase), MupO (P<sub>450</sub>), MacpE (acyl carrier protein, ACP) and MupV (putative didomain oxidoreductase/thioesterase). Dehydration (C7&#x02013;C8) of <bold>4</bold> catalysed by MupP (dehydratase) followed by two consecutive reductions by the oxidoreductases MupC (C6) and MupF (C7) gives PA-A (<bold>1</bold>).<sup><xref rid="cit8" ref-type="bibr">8</xref></sup> PA-C (<bold>3</bold>) is the product of a minor parallel pathway that branches from the main pathway (to PA-A).<sup><xref rid="cit9" ref-type="bibr">9</xref></sup></p><fig id="fig1" orientation="portrait" position="float"><label>Fig. 1</label><caption><title>(A) Summary of the later stages of mupirocin biosynthesis showing the parallel pathways. (B) Structures of selected thiomarinols. (C) Transformations of desepoxymupirocin P by the PKS mutant strain of <italic>Pseudoalteromonas</italic> SANK 73390.</title></caption><graphic xlink:href="c9sc06192d-f1"/></fig><p>A practical limitation of the major bioactive component, PA-A, is that the 10,11-epoxide moiety renders the molecule unstable outside a narrow pH range, due to formation of inactive bicyclic products arising from attack of the 7-OH onto the epoxide.<sup><xref rid="cit4" ref-type="bibr">4</xref></sup> In contrast, the minor metabolite PA-C, containing the 10,11-alkene, is much more stable. It is intriguing that in wild-type <italic>P. fluorescens</italic> 97% of total PAs and related metabolites contain or are derived from a 10,11-epoxide whereas the parallel minor biosynthetic pathway produces &#x0003c;3% of compounds with the 10,11-alkene (<italic>e.g.</italic> PA-C). In contrast, the closely related thiomarinols (<italic>e.g.</italic><bold>7</bold> and <bold>8</bold>) all possess a 10,11-alkene (<xref ref-type="fig" rid="fig1">Fig. 1B</xref>).</p><p>The thiomarinols are a family of marine natural products isolated from <italic>Pseudoalternomonas</italic> sp. SANK 73390 which also exhibit potent antibiotic activity against MRSA.<sup><xref rid="cit10" ref-type="bibr">10</xref></sup> They are assembled on a similar C<sub>17</sub>-polyketide moiety to the pseudomonic acids but differ in their esterification with an 8-hydroxyoctanoic acid (rather than 9-HN) side chain further linked as an amide to a pyrrothine subunit of the holomycin class of antibiotics. The major metabolite thiomarinol A (<bold>7</bold>) is also hydroxylated at C-4. Labelling studies are in accord with a PKS/NRPS origin of the thiomarinols.<sup><xref rid="cit11" ref-type="bibr">11</xref></sup> The mupirocin and thiomarinol gene clusters show significant homology but differences are evident.<sup><xref rid="cit12" ref-type="bibr">12</xref></sup> For example, homologues of the mupirocin standalone ACP MacpE along with MupU and MupV, necessary for conversion of PA-B to PA-A, are absent from SANK 73390. TmpB however contains additional ketosynthase (KS) and ACP domains as compared to MmpB, which are proposed to replace the apparent missing activities.<sup><xref rid="cit12" ref-type="bibr">12</xref></sup></p><p>Compared with the mupirocin pathway which has been readily modified,<sup><xref rid="cit9" ref-type="bibr">9</xref></sup> elucidating and engineering of the thiomarinol biosynthetic pathway in the marine organism has proved remarkably challenging. So far, only the <italic>&#x00394;tmlF</italic>, <italic>&#x00394;tmlU</italic>, and the mutant strains of <italic>Pseudoaltermonas</italic> sp. SANK 73390 in which the PKS and NRPS parts of the gene cluster have been deactivated have been successfully generated,<sup><xref rid="cit8" ref-type="bibr">8</xref></sup> all other gene knock-out studies (<italic>e.g.</italic>, <italic>&#x00394;tmlW</italic>) have failed to produce any isolable metabolites (unpublished results). Characterisation of the family of metabolites, including 8-hydroxythiomarinol C (<bold>9</bold>) (<xref ref-type="fig" rid="fig1">Fig. 1B</xref>) isolated from the <italic>&#x00394;tmlF</italic> mutant of <italic>Pseudoaltermonas</italic> sp. SANK 73390, combined with the processing of the THP ring observed on feeding desepoxymupirocin P (<bold>6</bold>) to the <italic>PKS</italic> mutant strain (<xref ref-type="fig" rid="fig1">Fig. 1C</xref>),<sup><xref rid="cit8" ref-type="bibr">8</xref></sup> indicates that it is likely that the late stage biosynthetic machinery generating both thiomarinols and PAs are closely related. However, details of the THP ring formation in thiomarinol biosynthesis remains to be proven experimentally. We now report <italic>in vitro</italic> functional characterisation of key enzymes from the thiomarinol pathway and results from engineering genes from the thiomarinol pathway into the mupirocin system as well as a comparison of the processing efficiency of 10,11-epoxy <italic>versus</italic> 10,11-alkenic metabolites at later stages of the mupirocin biosynthetic pathway. Furthermore, by optimisation of fermentation conditions, a significant increase in titres in cultures of mutants of <italic>P. fluorescens</italic> producing PA-C as the major metabolite has been achieved.</p></sec><sec><title>Results</title><p>To investigate the apparent differences in metabolite flux involving intermediates containing the 10,11-epoxide <italic>versus</italic> 10,11-alkenes, we focussed our investigations on two key parts of the mupirocin biosynthetic pathway involving mid and late stage transformations. The latter involves loss of the 8-OH going from PA-B (<bold>2</bold>) to PA-A (<bold>1</bold>) whereas the mid-stage steps occur post PKS-mediated backbone assembly and encompass 10,11-epoxidation, THP ring formation and fatty acid chain extension (<xref ref-type="fig" rid="fig1">Fig. 1A</xref>).</p><p>First to late stage processing: the conversion of desepoxy-PA-B (<bold>5</bold>) to PA-C (<bold>3</bold>) (<italic>i.e.</italic> loss of the 8-hydroxyl group in metabolites with the 10,11-alkene) was compared with the major pathway involving PA-B with the analogous 10,11-epoxide. PA-B (<bold>2</bold>) was isolated from cultures of the <italic>&#x00394;mupU</italic> mutant of <italic>P. fluorescens</italic> as previously described.<sup><xref rid="cit9" ref-type="bibr">9</xref></sup> However, a new mutant was required to access the corresponding 10,11-alkene, desepoxy-PA-B (<bold>5</bold>). MmpEOR has been identified as the epoxidase<sup><xref rid="cit9" ref-type="bibr">9</xref></sup> and thus the double mutant <italic>mmpE&#x00394;OR/&#x00394;mupU</italic> was generated and <bold>5</bold> was isolated from fermentations of this strain (see ESI, Fig. S1<xref ref-type="fn" rid="fn1">&#x02020;</xref>) in similar titres to that obtained for PA-B from the <italic>&#x00394;mupU</italic> mutant.</p><p>Two mutant strains, <italic>&#x00394;mupA</italic> and <italic>&#x00394;mupH</italic>, of <italic>P. fluorescens</italic> NCIMB 10586 were selected for the late stage mutasynthesis studies as neither produce any metabolites assembled on 6,7-dihydroxy-tetrahydropyrans.<sup><xref rid="cit9" ref-type="bibr">9</xref></sup> The same quantity of PA-B (<bold>2</bold>) and desepoxy-PA-B (<bold>5</bold>) was fed to cultures of each of the mutants and after 2 days' growth, products were analysed by LC-MS by comparison with standards for starting materials and products (PA-A <bold>1</bold> and PA-C <bold>3</bold>). Both substrates <bold>2</bold> (35% conversion) and <bold>5</bold> (75% conversion) were efficiently metabolised with overall loss of the 8-OH to PA-A and PA-C respectively (<xref ref-type="fig" rid="fig2">Fig. 2</xref>). Thus the steps involved in the removal of the 8-OH are not rate limiting in PA-C production and so do not account for the significantly different titres of PAs and related metabolites containing a 10,11-epoxide (97% of the total) compared with compounds with a 10,11-alkene including PA-C (&#x0003c;3%) in wild-type <italic>P. fluorescens</italic>.</p><fig id="fig2" orientation="portrait" position="float"><label>Fig. 2</label><caption><title>(A) Comparison of the processing of the 8-OH-10,11-epoxy PA (PA-B) with the analogous 10,11-alkene, desepoxy-PA-B. (B) HPLC traces: Conversion of PA-B (<bold>2</bold>) to PA-A (<bold>1</bold>) by the <italic>&#x00394;mupA</italic> and <italic>&#x00394;mupH</italic> mutants. (C) HPLC traces: Conversion of desepoxy-PA-B (<bold>5</bold>) to PA-C (<bold>3</bold>) by the <italic>&#x00394;mupA</italic> and <italic>&#x00394;mupH</italic> mutants.</title></caption><graphic xlink:href="c9sc06192d-f2"/></fig><p>Next, we turned to the mid-stage of mupirocin assembly and the key step involving tetrahydropyran (THP) ring formation. It has been shown previously that deletion of the oxygenase MupW (or its redox partner MupT) abolished production of the pseudomonic acids and led to accumulation of mupirocin W1 (<bold>14a</bold>) and W2 (<bold>14b</bold>) albeit in low titres.<sup><xref rid="cit9" ref-type="bibr">9,13</xref></sup> These metabolites lack the THP ring but contain a new tetrahydrofuran ring and are likely shunt products formed from the linear compounds <bold>13a</bold> and <bold>13b</bold> which undergo spontaneous intra-molecular attack by the 7-OH onto the 10,11-epoxide (<xref ref-type="fig" rid="fig3">Fig. 3A</xref>).<sup><xref rid="cit13" ref-type="bibr">13</xref></sup> Thus studies on THP formation on substrates possessing the 10,11-epoxide cannot be undertaken with linear substrates <bold>13a/b</bold>. However, using the corresponding 10,11-alkenes <bold>15a/b</bold> isolated from the <italic>mmpE&#x00394;OR/&#x00394;mupW</italic> strain we have recently shown that THP formation occurs <italic>via</italic> an oxidative enzyme-catalysed cascade by the dual action of the Rieske non-haem oxygenase MupW and the epoxide hydrolase MupZ.<sup><xref rid="cit14" ref-type="bibr">14</xref></sup> Selective oxidation of the C8&#x02013;C16 single bond in the acyclic precursors mupirocin W4 and W5 (<bold>15a/b</bold>) is proposed to give the corresponding 8,16-epoxide <bold>16</bold> (<xref ref-type="fig" rid="fig3">Fig. 3</xref>). In the absence of MupZ, the five-membered tetrahydrofuran ring products mupirocin Z1 and Z2 (<bold>17a/b</bold>) were isolated <italic>via</italic> spontaneous cyclisation (<xref ref-type="fig" rid="fig3">Fig. 3B</xref>).<sup><xref rid="cit14" ref-type="bibr">14</xref></sup></p><fig id="fig3" orientation="portrait" position="float"><label>Fig. 3</label><caption><title>(A) Structures of mupirocin W1 (<bold>14a</bold>) and W2 (<bold>14b</bold>) isolated from the <italic>&#x00394;mupW</italic> mutant of <italic>P. fluorescens</italic>. (B) THP ring formation in mupirocin biosynthesis catalysed by the dual action of the Rieske non-haem oxygenase MupW and the epoxide hydrolase MupZ.<sup><xref rid="cit14" ref-type="bibr">14</xref></sup> The functions of their equivalents TmlW/TmlZ in thiomarinol biosynthesis were confirmed in the present study.</title></caption><graphic xlink:href="c9sc06192d-f3"/></fig><p>TmlW and TmlZ from the thiomarinol gene cluster, show 55.8% and 56.3% identity, respectively, to MupW and MupZ. To investigate if the same mechanism of tetrahydropyran formation operates in both thiomarinol and mupirocin biosynthesis, TmlW was heterologously overexpressed in <italic>E. coli</italic> which is able to provide the additional redox partners and cofactors necessary to constitute an active cascade.<sup><xref rid="cit14" ref-type="bibr">14</xref></sup> Linear substrate mupirocin W5 (<bold>15b</bold>) was added to a whole-cell system using resting TmlW overexpressing <italic>E. coli</italic> cells supplemented with glucose to enable NAD(P)H regeneration (ESI<xref ref-type="fn" rid="fn1">&#x02020;</xref>). LC-MS indicated full conversion to a new product had occurred which on isolation and analysis by NMR spectroscopy was confirmed to be tetrahydrofuran mupirocin Z2 (<bold>17b</bold>), identical to that previously obtained from the whole live cells of the MupW overexpressing <italic>E. coli</italic> strain (Fig. S2<xref ref-type="fn" rid="fn1">&#x02020;</xref>). Furthermore, incubation of mupirocin W4 (<bold>15a</bold>) with <italic>E. coli</italic> cells overexpressing both MupW and TmlZ afforded the THP ring product desepoxy-PA-B (<bold>5</bold>) (Fig. S2<xref ref-type="fn" rid="fn1">&#x02020;</xref>). These results not only confirm that thiomarinol biosynthesis employs the same THP ring forming mechanism as that of mupirocin, but also demonstrate that these enzymes are cross compatible.</p><p>Unlike the major metabolites from wild-type <italic>P. fluorescens</italic> which contain the 10,11-epoxide, all thiomarinols isolated from <italic>Pseudoalteromonas</italic> sp. SANK 73390 have a 10,11-alkene. Having demonstrated MupW/TmlW and MupZ/TmlZ are functionally interchangeable we therefore investigated if replacing <italic>mupW</italic> with <italic>tmlW</italic> in the mupirocin gene cluster (<xref ref-type="fig" rid="fig4">Fig. 4A</xref>) would lead to more efficient processing of 10,11-alkenes <italic>versus</italic> 10,11-epoxides and hence alteration of the PA-C (<bold>3</bold>) to PA-A (<bold>1</bold>) ratio.</p><fig id="fig4" orientation="portrait" position="float"><label>Fig. 4</label><caption><title>(A) Comparison of the mupirocin (<italic>mup</italic>) and thiomarinol (<italic>tml</italic>) biosynthetic gene cluster, key genes involved in THP ring formation are highlighted in red, <italic>mupW</italic> is replaced by <italic>tmlW</italic> to form the chimeric pathway in this study. (B) Gene knock-out and knock-in by the two-step allelic exchange method. (C) PCR identification of the knock-out and knock-in mutants. (D) HPLC traces of the wild-type, <italic>&#x00394;mupW</italic> and <italic>&#x00394;mupW-tmlW</italic> mutants of <italic>P. fluorescens</italic>. (E) HPLC traces of the <italic>mmpE&#x00394;OR</italic>, <italic>mmpE&#x00394;OR/&#x00394;mupW</italic> and <italic>mmpE&#x00394;OR/&#x00394;mupW-tmlW</italic> mutants of <italic>P. fluorescens</italic>.</title></caption><graphic xlink:href="c9sc06192d-f4"/></fig><p>The entire <italic>mupW</italic> gene was firstly knocked out from the wild-type strain of <italic>P. fluorescens</italic> using the two-step allelic exchange method (<xref ref-type="fig" rid="fig4">Fig. 4B</xref>).<sup><xref rid="cit14" ref-type="bibr">14,15</xref></sup> Desired mutants were screened by PCR and confirmed by Sanger sequencing (<xref ref-type="fig" rid="fig4">Fig. 4C</xref>). The resulting <italic>&#x00394;mupW</italic> mutant produced only the THF-containing shunt products mupirocin W1 and W2 (<bold>14a/b</bold>) (<xref ref-type="fig" rid="fig4">Fig. 4D</xref>). <italic>TmlW</italic> was then introduced into the <italic>&#x00394;mupW</italic> strain at the same locus from which <italic>mupW</italic> was removed, using the same genetic manipulation approach. This new hybrid mutant, <italic>P. fluorescens &#x00394;mupW-tmlW</italic>, was cultured in parallel with the original wild-type <italic>P. fluorescens</italic> under the same fermentation conditions. This restored PA-A production and the ratio of PA-C (trace) to PA-A (major) in cultures of the mutant strain was equivalent to that obtained for wild-type <italic>P. fluorescens</italic> (<xref ref-type="fig" rid="fig4">Fig. 4D</xref>).</p><p>Next, the same knockout&#x02013;knockin approach was applied to the <italic>mmpE&#x00394;OR</italic> mutant of <italic>P. fluorescens</italic> which only produces PA-C. The <italic>mmpE&#x00394;OR/&#x00394;mupW</italic> mutant abolished PA-C production and gave only the acyclic metabolites mupirocin W4 and W5 (<bold>15a/b</bold>) (<xref ref-type="fig" rid="fig4">Fig. 4E</xref>). The new hybrid mutant <italic>mmpE&#x00394;OR/&#x00394;mupW-tmlW</italic> restored PA-C production, and titres were similar as compared to <italic>mmpE&#x00394;OR</italic> (<xref ref-type="fig" rid="fig4">Fig. 4E</xref>).</p><p>During our investigations we found that the titres of mupirocin metabolites from both wild-type <italic>P. fluorescens</italic> and mutants were variable and hence we undertook a systematic investigation to improve both the reproducibility and importantly the levels of metabolite production. Fermentation media, incubation time and temperature, shaking speed <italic>etc.</italic> were optimised for PA-C production. The key observation was that when the <italic>mmpE&#x00394;OR</italic> mutant was grown for 2 days at 22 &#x000b0;C in LB-broth supplemented with 4% glucose, the titres of PA-C (<bold>3</bold>) reached a reproducible level of <italic>ca.</italic> 40 mg L<sup>&#x02212;1</sup> in baffled flasks compared to <italic>ca.</italic> 2 mg L<sup>&#x02212;1</sup> in unbaffled flasks (<xref ref-type="fig" rid="fig5">Fig. 5</xref> and S3<xref ref-type="fn" rid="fn1">&#x02020;</xref>). Minor metabolites isolated under these conditions include a 4&#x02009;:&#x02009;1 mixture of desepoxy-PA-B (<bold>5</bold>) with mupirocin Z1 (<bold>17a</bold>) (<xref ref-type="fig" rid="fig5">Fig. 5</xref> and S4<xref ref-type="fn" rid="fn1">&#x02020;</xref>), and the newly identified desepoxy-PA-D (<bold>19</bold>) (<xref ref-type="fig" rid="fig5">Fig. 5</xref>, Table S1 and Fig. S5&#x02013;S10<xref ref-type="fn" rid="fn1">&#x02020;</xref>). The new hybrid mutant <italic>mmpE&#x00394;OR/&#x00394;mupW-tmlW</italic> showed a similar result, again indicating their equivalent effectiveness in initiating THP ring formation. Interestingly, increased aeration during fermentation of cultures of mutants acting early in the pathway led to no detectible differences in titres of accumulated acyclic intermediates such as <bold>15a</bold> and <bold>15b</bold>.</p><fig id="fig5" orientation="portrait" position="float"><label>Fig. 5</label><caption><title>HPLC trace of the <italic>mmpE&#x00394;OR</italic> mutant cultured in baffled flasks compared to in unbaffled flasks.</title></caption><graphic xlink:href="c9sc06192d-f5"/></fig><p>With significant quantities of PA-C now available, antibiotic activity screening of PA-C, along with PA-A and PA-B, against a range of Gram-positive bacteria (<xref rid="tab1" ref-type="table">Table 1</xref>) was undertaken. The more chemically stable PA-C (<bold>3</bold>) exhibited comparable antibiotic activity to PA-A, with, notably, similar activity against the four <italic>Staphylococcus aureus</italic> strains tested, including the Mu50 strain that both exhibits a methicillin-resistant (MRSA) phenotype and reduced susceptibility to glycopeptides including vancomycin. These data confirm the effectiveness of monic acid-based agents against Gram-positive pathogens, including strains challenging to treat with first-line antibiotics, and that antibacterial activity is not adversely affected by substitution of the 10,11-epoxide of mupirocin for the 10,11-alkene. Notably, PA-B displayed substantially lower activity in all susceptibility assays. As PA-B and desepoxy-PA-B are normally intermediates towards the mature antibiotics PA-A and PA-C, respectively, this may be of physiological significance in terms of self-resistance.</p><table-wrap id="tab1" orientation="portrait" position="float"><caption><title>Minimum Inhibitory Concentration (MIC, &#x003bc;g mL<sup>&#x02212;1</sup>) of PA-A (<bold>1</bold>), PA-B (<bold>2</bold>) and PA-C (<bold>3</bold>) against Gram-positive bacteria. Values were obtained from microplate broth dilution</title></caption><table frame="hsides" rules="groups"><colgroup span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><th rowspan="1" colspan="1">Strains</th><th rowspan="1" colspan="1">PA-A (<bold>1</bold>)</th><th rowspan="1" colspan="1">PA-B (<bold>2</bold>)</th><th rowspan="1" colspan="1">PA-C (<bold>3</bold>)</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">
<italic>Bacillus subtilis</italic>
</td><td align="char" char="." rowspan="1" colspan="1">0.06</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">&#x0003c;0.03</td></tr><tr><td rowspan="1" colspan="1">
<italic>S. aureus</italic> ATCC 29213</td><td align="char" char="." rowspan="1" colspan="1">0.125</td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">0.25</td></tr><tr><td rowspan="1" colspan="1">
<italic>S. aureus</italic> Newman</td><td align="char" char="." rowspan="1" colspan="1">0.125</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">0.125</td></tr><tr><td rowspan="1" colspan="1">
<italic>S. aureus</italic> NCTC 6571</td><td align="char" char="." rowspan="1" colspan="1">0.125</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">0.125</td></tr><tr><td rowspan="1" colspan="1">
<italic>S. aureus</italic> Mu50</td><td align="char" char="." rowspan="1" colspan="1">0.125</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">0.125</td></tr><tr><td rowspan="1" colspan="1">
<italic>S. epidermidis</italic> NCTC 11047</td><td align="char" char="." rowspan="1" colspan="1">0.125</td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">0.5</td></tr></tbody></table></table-wrap></sec><sec><title>Conclusions and discussion</title><p>In conclusion we have demonstrated that the late-stage processing in mupirocin biosynthesis of the 10,11-alkene is as efficient as the 10,11-epoxide and that transformations leading to the removal of the 8-hydroxyl groups do not account for the very different levels of PA-A and PA-C production in WT <italic>P. fluorescens</italic>. Epoxidation catalysed by MmpE is presumably very efficient. The mupirocin pathway was engineered with heterologous genes from the thiomarinol pathway thereby demonstrating that genes from the marine organism <italic>Pseudoalternomonas</italic> sp. SANK 73390 can be expressed in functional form in the soil bacterium <italic>P. fluorescens</italic>. Furthermore, it is revealed that both pathways employ the same unusual mechanism of tetrahydropyran (THP) ring formation and that the enzymes responsible for this activity are cross compatible.</p><p>Whilst the mupirocin and thiomarinol gene clusters show high homology, there are significant differences.<sup><xref rid="cit12" ref-type="bibr">12</xref></sup> Genetic engineering of the thiomarinol pathway in the marine organism has, however, proved remarkably difficult (only four mutants have been reported to date<sup><xref rid="cit8" ref-type="bibr">8</xref></sup>), leading to significant challenges in elucidating the biosynthesis of these marine natural products. We envisage that heterologous expression of components from the thiomarinol pathway in the mupirocin producer will provide an alternative approach elucidating their biosynthesis.</p><p>Access to engineered strains of <italic>P. fluorescens</italic> in which the major product is the more stable PA-C, rather than PA-A in wild type, has potential for industrial scale production of PA-C and subsequent further development as a more stable antibiotic with wider applications than mupirocin.</p><p>The plug-and-play approach for the assembly of heterologous genes in the mupirocin biosynthetic gene cluster will be useful for further engineering of polyketide biosynthesis. By building on existing polyketide engineering and characterisation strategies, harnessing current synthetic biology technologies, and utilising advances in metabolic/host engineering, we anticipate future successes in engineering PKSs capable of producing designer polyketides for applications in medicine, fuels, and industrial products.<sup><xref rid="cit16" ref-type="bibr">16</xref></sup></p></sec><sec sec-type="COI-statement"><title>Conflicts of interest</title><p>There are no conflicts to declare.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SC-011-C9SC06192D-s001"><label>SC-011-C9SC06192D-s001</label><media xlink:href="SC-011-C9SC06192D-s001.pdf" orientation="portrait" id="d24e995" position="anchor"/></supplementary-material></sec></body><back><ack><p>The authors thank the BBSRC and EPSRC for funding BB/R007853/1 and through the Bristol Centre for Synthetic Biology (BB/L01386X/1) and the EPSRC BristolBridge Award (EP/M027546/1).</p></ack><ref-list><title>Notes and references</title><ref id="cit1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chellat</surname><given-names>M. F.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Ragu&#x0017e;</surname><given-names>L.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Riedl</surname><given-names>R.</given-names></name></person-group><source>Angew. Chem., Int. Ed.</source><year>2016</year><volume>55</volume><fpage>6600</fpage><lpage>6626</lpage><pub-id pub-id-type="doi">10.1002/anie.201506818</pub-id><?supplied-pmid 27000559?><pub-id pub-id-type="pmid">27000559</pub-id></element-citation></ref><ref id="cit2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>E.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Moore</surname><given-names>B. S.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Yoon</surname><given-names>Y. J.</given-names></name></person-group><source>Nat. Chem. Biol.</source><year>2015</year><volume>11</volume><fpage>649</fpage><lpage>659</lpage><pub-id pub-id-type="doi">10.1038/nchembio.1893</pub-id><?supplied-pmid 26284672?><pub-id pub-id-type="pmid">26284672</pub-id></element-citation></ref><ref id="cit3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Breitling</surname><given-names>R.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Takano</surname><given-names>E.</given-names></name></person-group><source>Cold Spring Harbor Perspect. Biol.</source><year>2016</year><volume>8</volume><fpage>a023994</fpage><pub-id pub-id-type="doi">10.1101/cshperspect.a023994</pub-id><?supplied-pmid 27503995?><pub-id pub-id-type="pmid">27503995</pub-id></element-citation></ref><ref id="cit4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>C. M.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Hothersall</surname><given-names>J.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Willis</surname><given-names>C. L.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Simpson</surname><given-names>T. J.</given-names></name></person-group><source>Nat. Rev. Microbiol.</source><year>2010</year><volume>8</volume><fpage>281</fpage><lpage>289</lpage><pub-id pub-id-type="doi">10.1038/nrmicro2278</pub-id><?supplied-pmid 20190824?><pub-id pub-id-type="pmid">20190824</pub-id></element-citation></ref><ref id="cit5"><element-citation publication-type="journal" id="cit5a"><label> (a) </label><person-group person-group-type="author"><name><surname>Piel</surname><given-names>J.</given-names></name></person-group><source>Nat. Prod. Rep.</source><year>2010</year><volume>27</volume><fpage>996</fpage><lpage>1047</lpage><pub-id pub-id-type="doi">10.1039/B816430B</pub-id><?supplied-pmid 20464003?><pub-id pub-id-type="pmid">20464003</pub-id></element-citation><element-citation publication-type="journal" id="cit5b"><label> (b) </label><person-group person-group-type="author"><name><surname>Helfrich</surname><given-names>E. J.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Piel</surname><given-names>J.</given-names></name></person-group><source>Nat. Prod. Rep.</source><year>2016</year><volume>33</volume><fpage>231</fpage><lpage>316</lpage><pub-id pub-id-type="doi">10.1039/C5NP00125K</pub-id><?supplied-pmid 26689670?><pub-id pub-id-type="pmid">26689670</pub-id></element-citation></ref><ref id="cit6"><element-citation publication-type="journal" id="cit6a"><label> (a) </label><person-group person-group-type="author"><name><surname>Fuller</surname><given-names>A. T.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Mellows</surname><given-names>G.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Woolford</surname><given-names>M.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Banks</surname><given-names>G. T.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Barrow</surname><given-names>K. D.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Chain</surname><given-names>E. B.</given-names></name></person-group><source>Nature</source><year>1971</year><volume>234</volume><fpage>416</fpage><lpage>417</lpage><pub-id pub-id-type="doi">10.1038/234416a0</pub-id><?supplied-pmid 5003547?><pub-id pub-id-type="pmid">5003547</pub-id></element-citation><element-citation publication-type="journal" id="cit6b"><label> (b) </label><person-group person-group-type="author"><name><surname>Chain</surname><given-names>E. B.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Mellows</surname><given-names>G.</given-names></name></person-group><source>J. Chem. Soc., Perkin Trans. 1</source><year>1977</year><fpage>294</fpage><lpage>309</lpage><pub-id pub-id-type="doi">10.1039/P19770000294</pub-id></element-citation><element-citation publication-type="journal" id="cit6c"><label> (c) </label><person-group person-group-type="author"><name><surname>Chain</surname><given-names>E. B.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Mellows</surname><given-names>G.</given-names></name></person-group><source>J. Chem. Soc., Perkin Trans. 1</source><year>1977</year><fpage>318</fpage><lpage>322</lpage><pub-id pub-id-type="doi">10.1039/P19770000318</pub-id></element-citation></ref><ref id="cit7"><element-citation publication-type="journal" id="cit7a"><label> (a) </label><person-group person-group-type="author"><name><surname>Mantle</surname><given-names>P. G.</given-names></name></person-group><person-group person-group-type="author"><name><surname>De Langen</surname><given-names>M.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Teo</surname><given-names>V. K.</given-names></name></person-group><source>J. Antibiot.</source><year>2001</year><volume>54</volume><fpage>166</fpage><lpage>174</lpage><pub-id pub-id-type="doi">10.7164/antibiotics.54.166</pub-id><?supplied-pmid 11302490?><pub-id pub-id-type="pmid">11302490</pub-id></element-citation><element-citation publication-type="journal" id="cit7b"><label> (b) </label><person-group person-group-type="author"><name><surname>Hothersall</surname><given-names>J.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Wu</surname><given-names>J. e.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Rahman</surname><given-names>A. S.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Shields</surname><given-names>J. A.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Haddock</surname><given-names>J.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>N.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>S. M.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Stephens</surname><given-names>E. R.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Cox</surname><given-names>R. J.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Crosby</surname><given-names>J.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Willis</surname><given-names>C. L.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Simpson</surname><given-names>T. J.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>C. M.</given-names></name></person-group><source>J. Biol. Chem.</source><year>2007</year><volume>282</volume><fpage>15451</fpage><lpage>15461</lpage><pub-id pub-id-type="doi">10.1074/jbc.M701490200</pub-id><?supplied-pmid 17383964?><pub-id pub-id-type="pmid">17383964</pub-id></element-citation></ref><ref id="cit8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>S.-S.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Song</surname><given-names>Z.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Hothersall</surname><given-names>J.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Stevens</surname><given-names>E. R.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Connolly</surname><given-names>J.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Winn</surname><given-names>P. J.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Cox</surname><given-names>R. J.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Crump</surname><given-names>M. P.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Race</surname><given-names>P. R.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>C. M.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Simpson</surname><given-names>T. J.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Willis</surname><given-names>C. L.</given-names></name></person-group><source>Angew. Chem., Int. Ed.</source><year>2017</year><volume>56</volume><fpage>3930</fpage><lpage>3934</lpage><pub-id pub-id-type="doi">10.1002/anie.201611590</pub-id><?supplied-pmid 28181382?><pub-id pub-id-type="pmid">28181382</pub-id></element-citation></ref><ref id="cit9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>S.-S.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Hothersall</surname><given-names>J.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Wu</surname><given-names>J.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>A. C.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Song</surname><given-names>Z.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Stephens</surname><given-names>E. R.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>C. M.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Crump</surname><given-names>M. P.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Cox</surname><given-names>R. J.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Simpson</surname><given-names>T. J.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Willis</surname><given-names>C. L.</given-names></name></person-group><source>J. Am. Chem. Soc.</source><year>2014</year><volume>136</volume><fpage>5501</fpage><lpage>5507</lpage><pub-id pub-id-type="doi">10.1021/ja501731p</pub-id><?supplied-pmid 24625190?><pub-id pub-id-type="pmid">24625190</pub-id></element-citation></ref><ref id="cit10"><element-citation publication-type="journal" id="cit10a"><label> (a) </label><person-group person-group-type="author"><name><surname>Shiozawa</surname><given-names>H.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Kagasaki</surname><given-names>T.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Kinoshita</surname><given-names>T.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Haruyama</surname><given-names>H.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Domon</surname><given-names>H.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Utsui</surname><given-names>Y.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Kodama</surname><given-names>K.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>S.</given-names></name></person-group><source>J. Antibiot.</source><year>1993</year><volume>46</volume><fpage>1834</fpage><lpage>1842</lpage><pub-id pub-id-type="doi">10.7164/antibiotics.46.1834</pub-id><?supplied-pmid 8294241?><pub-id pub-id-type="pmid">8294241</pub-id></element-citation><element-citation publication-type="journal" id="cit10b"><label> (b) </label><person-group person-group-type="author"><name><surname>Shiozawa</surname><given-names>H.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Kagasaki</surname><given-names>T.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Torikata</surname><given-names>A.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>N.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Fujimoto</surname><given-names>K.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Hata</surname><given-names>T.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Furukawa</surname><given-names>Y.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>S.</given-names></name></person-group><source>J. Antibiot.</source><year>1995</year><volume>48</volume><fpage>907</fpage><lpage>909</lpage><pub-id pub-id-type="doi">10.7164/antibiotics.48.907</pub-id><?supplied-pmid 7592043?><pub-id pub-id-type="pmid">7592043</pub-id></element-citation><element-citation publication-type="journal" id="cit10c"><label> (c) </label><person-group person-group-type="author"><name><surname>Shiozawa</surname><given-names>H.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Shimada</surname><given-names>A.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>S.</given-names></name></person-group><source>J. Antibiot.</source><year>1997</year><volume>50</volume><fpage>449</fpage><lpage>452</lpage><pub-id pub-id-type="doi">10.7164/antibiotics.50.449</pub-id><?supplied-pmid 9207918?><pub-id pub-id-type="pmid">9207918</pub-id></element-citation></ref><ref id="cit11"><element-citation publication-type="journal" id="cit11a"><label> (a) </label><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>aA. C.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Fukuda</surname><given-names>D.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Song</surname><given-names>Z.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Hothersall</surname><given-names>J.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Cox</surname><given-names>R. J.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Willis</surname><given-names>C. L.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>C. M.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Simpson</surname><given-names>T. J.</given-names></name></person-group><source>Angew. Chem., Int. Ed.</source><year>2011</year><volume>50</volume><fpage>3271</fpage><lpage>3274</lpage><pub-id pub-id-type="doi">10.1002/anie.201007029</pub-id><?supplied-pmid 21381163?><pub-id pub-id-type="pmid">21381163</pub-id></element-citation><element-citation publication-type="journal" id="cit11b"><label> (b) </label><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>A. C.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Gao</surname><given-names>S.-S.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Han</surname><given-names>L.-C.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Carobene</surname><given-names>S.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Fukuda</surname><given-names>D.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Song</surname><given-names>Z.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Hothersall</surname><given-names>J.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Cox</surname><given-names>R. J.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Crosby</surname><given-names>J.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Crump</surname><given-names>M. P.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>C. M.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Willis</surname><given-names>C. L.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Simpson</surname><given-names>T. J.</given-names></name></person-group><source>Chem. Sci.</source><year>2014</year><volume>5</volume><fpage>397</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.1039/C3SC52281D</pub-id></element-citation></ref><ref id="cit12"><element-citation publication-type="journal" id="cit12a"><label> (a) </label><person-group person-group-type="author"><name><surname>El-Sayed</surname><given-names>A. K.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Hothersall</surname><given-names>J.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>S. M.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Stephens</surname><given-names>E.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Simpson</surname><given-names>T. J.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>C. M.</given-names></name></person-group><source>Chem. Biol.</source><year>2003</year><volume>10</volume><fpage>419</fpage><lpage>430</lpage><pub-id pub-id-type="doi">10.1016/S1074-5521(03)00091-7</pub-id><?supplied-pmid 12770824?><pub-id pub-id-type="pmid">12770824</pub-id></element-citation><element-citation publication-type="journal" id="cit12b"><label> (b) </label><person-group person-group-type="author"><name><surname>Fukuda</surname><given-names>D.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Haines</surname><given-names>A. S.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Song</surname><given-names>Z.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>A.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Hothersall</surname><given-names>J.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Stephens</surname><given-names>E. R.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Gurney</surname><given-names>R.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Riemer</surname><given-names>C.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Marshall</surname><given-names>R.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Cox</surname><given-names>R. J.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Crosby</surname><given-names>J.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Willis</surname><given-names>C. L.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Simpson</surname><given-names>T. J.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>C. M.</given-names></name></person-group><source>PLoS One</source><year>2011</year><volume>6</volume><fpage>e10831</fpage></element-citation></ref><ref id="cit13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>S. M.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Cox</surname><given-names>R. J.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Crosby</surname><given-names>J.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Crump</surname><given-names>M. P.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Hothersall</surname><given-names>J.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Laosripaiboon</surname><given-names>W.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Simpson</surname><given-names>T. J.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>C. M.</given-names></name></person-group><source>Chem. Commun.</source><year>2005</year><fpage>1179</fpage><lpage>1181</lpage><pub-id pub-id-type="doi">10.1039/B414781B</pub-id><?supplied-pmid 15726184?><pub-id pub-id-type="pmid">15726184</pub-id></element-citation></ref><ref id="cit14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Parnell</surname><given-names>A.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Williams</surname><given-names>C.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Bakar</surname><given-names>N. A.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Challand</surname><given-names>M. R.</given-names></name></person-group><person-group person-group-type="author"><name><surname>van der Kamp</surname><given-names>M. W.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Simpson</surname><given-names>T. J.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Race</surname><given-names>P. R.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Crump</surname><given-names>M. P.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Willis</surname><given-names>C. L.</given-names></name></person-group><source>Nat. Catal.</source><year>2018</year><volume>1</volume><fpage>968</fpage><lpage>976</lpage><pub-id pub-id-type="doi">10.1038/s41929-018-0183-5</pub-id></element-citation></ref><ref id="cit15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hmelo</surname><given-names>L. R.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Borlee</surname><given-names>B. R.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Almblad</surname><given-names>H.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Love</surname><given-names>M. E.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Randall</surname><given-names>T. E.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Tseng</surname><given-names>B. S.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Lin</surname><given-names>C.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Irie</surname><given-names>Y.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Storek</surname><given-names>K. M.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J. J.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Siehnel</surname><given-names>R. J.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Howell</surname><given-names>P. L.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Singh</surname><given-names>P. K.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Tolker-Nielsen</surname><given-names>T.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Parsek</surname><given-names>M. R.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Schweizer</surname><given-names>H. P.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Harrison</surname><given-names>J. J.</given-names></name></person-group><source>Nat. Protoc.</source><year>2015</year><volume>10</volume><fpage>1820</fpage><lpage>1841</lpage><pub-id pub-id-type="doi">10.1038/nprot.2015.115</pub-id><?supplied-pmid 26492139?><pub-id pub-id-type="pmid">26492139</pub-id></element-citation></ref><ref id="cit16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barajas</surname><given-names>J. F.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Blake-Hedges</surname><given-names>J. M.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Bailey</surname><given-names>C. B.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Curran</surname><given-names>S.</given-names></name></person-group><person-group person-group-type="author"><name><surname>Keasling</surname><given-names>J. D.</given-names></name></person-group><source>Synth. Syst. Biotechnol.</source><year>2017</year><volume>2</volume><fpage>147</fpage><lpage>166</lpage><pub-id pub-id-type="doi">10.1016/j.synbio.2017.08.005</pub-id><?supplied-pmid 29318196?><pub-id pub-id-type="pmid">29318196</pub-id></element-citation></ref></ref-list></back></article>